PSI Webinar - Overview and awareness about quantitative decision-making in drug development
Date: 3 December 2019
Time: 14:00 - 15:30
Speakers: PSI/EFSPI SIG Quantitative Decision-Making members:
- Véronique Robert (Servier)
- Guido Thömmes (Grunenthal)
- Oliver Sailer (Boehringer-Ingelheim)
We performed a survey among pharmaceutical companies, targeting people with different profiles (statisticians, non-statisticians and decision-makers) working at different stages of the clinical development (study level, development level or portfolio level). This survey allowed us to analyze which quantitative methods are known, which quantitative methods are used (or not), what benefit is expected from this kind of methods, and what are the needs for a larger use of quantitative methods to support decision-making. It permitted to understand the gaps and some of the issues associated to the use of such methods in drug development. The webinars are intended to share the learnings from the survey and to promote different quantitative methods for decision-making.
to register for this free event please click here
Please email PSI@mci-group.com
if you have any questions.